(Q45294206)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323798%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Meeting report: myelodysplastic syndromes at ASH 2007 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323798%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

C Gardin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323798%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

6 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323798%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323798%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323798%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323798%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

893-897

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323798%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2008.45

3 January 2020

exact match

0 references

cites work

Modifying the epigenome as a therapeutic strategy in myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Loss of Hspa9b in zebrafish recapitulates the ineffective hematopoiesis of the myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Impaired ribosome biogenesis in Diamond-Blackfan anemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Single nucleotide polymorphism array analysis of cancer.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Marrow stroma in MDS: culprit or bystander?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Expression and prognostic significance of Bcl-2 family proteins in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.45

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323798%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

3 January 2020

1014773734

0 references

1 reference